?? Oxford University Innovation Launches its 2024 Impact Report! ?? Check out Shaping the Future: Oxford’s Innovation Impact, our second impact report that showcases how we’re developing cutting-edge research into powerful, tangible impacts for society, the economy, and the environment. From AI-driven health solutions to sustainable energy breakthroughs, Oxford’s innovation ecosystem is transforming communities around the world. ?? Explore this year’s highlights: ?? Pioneering new spinouts like Brainomix, using AI to revolutionise stroke care ?? Supporting social ventures such as Greater Change, empowering people to overcome homelessness ?? Inspiring spinouts like Mixergy Ltd., which has a mission to cut CO? emissions and reduce energy costs Help us celebrate University of Oxford and Oxford University Innovation's role in shaping a brighter, more sustainable future. Read more ?? https://lnkd.in/ehHJk9Ug Oxford University Innovation University of Oxford Brainomix Greater Change Mixergy Ltd Onfido Oxford Semantic Technologies Sa?d Business School, University of Oxford EnSpire Oxford OMRON Group Oxehealth MeVitae Stuart Gillespie Inkpath Limited The A-Day OxProx Covatic #ImpactReport2024 #StartedinOxford #ShapingTheFuture #SocialImpact #EnvironmentalImpact #Innovation
Oxford University Innovation
投资管理
Building a world-leading innovation ecosystem with Oxford University at its heart.
关于我们
Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner. Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. We support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact.
- 网站
-
https://www.innovation.ox.ac.uk
Oxford University Innovation的外部链接
- 所属行业
- 投资管理
- 规模
- 51-200 人
- 总部
- Oxford
- 类型
- 私人持股
- 创立
- 1987
- 领域
- Technology Transfer、University Consulting、Commercialisation、Consultancy、Angel investment、Innovation、Technology licensing、Spinout company formation、Research commercialisation和Startups
地点
-
主要
获取路线
Buxton Court
3 West Way
GB，Oxford，OX2 0JB
Oxford University Innovation员工
动态
-
???Transforming liver disease diagnosis with innovation from Oxford??? ? We’re thrilled to spotlight?Perspectum Ltd, a University of Oxford spinout supported by Oxford University Innovation, whose latest study on LiverMultiScan is setting new standards in liver disease management. Published in Nature Communications Medicine, the research shows how this advanced MRI technology can reduce the need for invasive biopsies, improve diagnosis rates, and lower healthcare costs for patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). With MASLD affecting a growing number of people globally, LiverMultiScan offers a faster, safer, and more cost-effective solution, promising to reshape how clinicians approach liver health.? ? Congratulations?to Elizabeth Shumbayawonda Marika French Cayden Beyer @Paula Lorgelly & Rajarshi Banerjee from the Perspectum team for leading the way with this game-changing innovation! #perspectum #liverdisease #medtech #innovation #masld
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease A new, multinational study in Nature Portfolio shows that LiverMultiScan can reduce liver biopsies, lead to fewer specialist consultations, and improve the rate of diagnosis for patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Key Findings from the Study: ? 50% fewer biopsies - a safer, pain-free diagnostic pathway ? 10% improvement in diagnosis rates compared to standard care ? Fewer hospital & specialist visits - reducing patient burden & healthcare costs ? Proven cost-effectiveness: €4,929 ($5,369) per QALY gained With MASLD affecting 30% of people across North America and Europe, these findings reshape how we diagnose and manage liver disease - right as the first treatments become widely available. A huge thank-you to Elizabeth Shumbayawonda, Marika French, Cayden Beyer, Paula Lorgelly, Dimitar Tonev, Rajarshi Banerjee, Michael H. Miller, Christopher D. Byrne, Janisha Patel, Saima Ajaz, Kosh Agarwal, Johanna Fischer Backhus, Minneke Coenraad, Jelte J. Schaapman, Andrew Fraser, Luis Miguel Nú?ez, Stephen Black, Matthias M. Dollinger, Daniel Cuthbertson, Daniel Forton & Hildo J. Lamb, MD, PhD ??Read the full paper: https://lnkd.in/e97BksPg ??Read the full press release: https://lnkd.in/e4b6F5q6 #Perspectum #LiverMultiScan #NewWayToSeeHealth #MASLD #Diagnostics #TechForGood #LiverHealth
-
?? Join Oxford University Innovation – Licence & Alliance Manager Opportunity ???? Oxford University Innovation (OUI) is at the forefront of transforming world-class research into real-world impact. From accelerating the Oxford/AZ Covid-19 vaccine ??to launching spinouts like Oxford Nanopore Technologies ??, we’re shaping the future of innovation. We’re looking for a Licence & Alliance Manager to join our team. In this role, you’ll manage a portfolio of licences, key partnerships, and intellectual property across Life and Physical Sciences - helping turn university research into commercial success. ?? Do you have a science background and a passion for innovation? ?? Are you skilled in stakeholder management, IP strategy, and deal-making? ?? Do you thrive in collaborative, impact-driven environments? If this sounds like you, apply now and be part of Oxford’s world-leading enterprise team! Deadline: 19th March 2025. ?? Find out more & apply here: https://lnkd.in/e-ESNsxp #hiring #innovation #techtransfer #sciencetoimpact
-
Exciting news from Caristo Diagnostics! Their heart disease detection technology has received FDA approval ??
Caristo officially enters the U.S. market! FDA has granted 510(k) clearance for Caristo’s CaRi-Plaque technology.???? ?? Our AI-assisted CaRi-Plaque? technology builds on our core CaRi-Heart? technology to deliver precision in coronary plaque detection and stenosis quantification, helping cardiologists and radiologists analyze type, volume, and severity of plaque.? ?? ???Read our press release to learn more about CaRi-Plaque technology.?https://lnkd.in/dB9k73ys #Plaqueanalysis #AI #medicalimaging #Cardiacimaging #cardiovasculardisease #prevention #plaque #inflammation #cardiology
-
-
Oxford University Innovation转发了
?? Our series of interview blogs celebrating remarkable women continues! We are highlighting the journeys of exceptional women in knowledge exchange, sharing their experiences, challenges, and successes. Today, we feature Jaci Barnett, RTTP, Chief Operating Officer at Oxford University Innovation. Read her story here: https://lnkd.in/d4nG58pR #KnowledgeExchangeUK #KEUK #InternationalWomensDay #IWD #KnowledgeExchange
-
-
?? Exciting news for sustainable innovation! ?? We’re thrilled to welcome OXCCU TECH LTD to the Oxford Innovation Society (OIS). Their pioneering work in converting carbon dioxide into sustainable aviation fuels and chemicals directly tackles one of the world’s most pressing challenges: climate change. This partnership comes at a crucial moment, with 2025 set to be a landmark year for clean tech. Events like the Right Here Right Now Global Climate Alliance summit in June highlight the growing momentum in the sector. OXCCU joins a thriving network of impact-driven OIS members, including Oxfordshire Greentech, creating a thriving cluster of innovators dedicated to sustainability and societal progress. ?? We look forward to driving real change together through innovation and collaboration. Oxford University Innovation #innovation #sustainability #cleantech #ois #collaboration?
-
?? Join Oxford University Innovation and Oxford Chemistry on Tuesday, 18 March, for an exclusive fireside chat with OMass Therapeutics founders, Professor Dame Carol Robinson and Dr Idlir Liko. Carol and Idlir will share insights from their entrepreneurial journey, which led to the creation of Oxford spinout OMass Therapeutics - a pioneering drug discovery company developing treatments for rare immunological and genetic diseases. This expert panel discussion will be followed by a short drinks reception. Open to all University of Oxford staff and students - register now to secure your place! ?? https://lnkd.in/e9q6AGBh #innovation #entrepeneurship #studententrepreneurship #oxfordstudents
-
?? Oxford Edge is here! ?? Christ Church, Oxford is launching Oxford Edge, the city’s newest centre for student innovation and entrepreneurship. Join them for an Open House tomorrow - Friday, 7 March, from 2:30 - 4:30 pm - at 37 St Giles. Drop by for a tour, meet like-minded students, and explore the resources available to help bring your entrepreneurial ideas to life. Be one of the first to see Oxford Edge! ?? When? Friday, 7 March, 2:30 - 4:30 pm ?? Where? 37 St Giles, Oxford ?? Who? Open to all Oxford students—just bring your uni card University of Oxford #oxfordedge #entrepreneurship #innovation #oxfordstudents #startedinoxford
-
Oxford University Innovation at #AUTM2025 Today, our CEO, Mairi Gibbs, will be speaking at the AUTM Conference, joining an important panel discussion titled 'Global Health – 25 Years After Stavudine, Where Do We Stand?' This session will explore the evolving role of universities in ensuring equitable access to medical innovations, revisiting key licensing practices and their impact on global health. With academic research playing a critical role in shaping healthcare worldwide, this conversation is more relevant than ever. #AUTM50 #Innovation #GlobalHealth #AcademicResearch #TechnologyTransfer
-
Great to see this post from Oxford BioDynamics Plc, showcasing how their work on #EpiSwitchPSE is shaping the future of prostate cancer detection. With 94% accuracy, this test could transform early diagnosis and improve outcomes for thousands of men. At Oxford University Innovation, we are proud to support pioneering research like this that leads to real-world impact. #lifesciences #biotech #earlydetectionsaveslives #prostatecancer
Prostate cancer is the most common cancer among men, yet too many cases are caught too late. Rishi Sunak and Prostate Cancer Research are pushing for change, and we are proud to stand with them. Thank you, Mr. Sunak, for coming to meet the scientists who developed the #EpiSwitchPSE. We look forward to working together to make #ProstateCancer testing available to everyone who needs it. #EarlyDetectionSavesLives Read more in the Daily Mail: obdx.co/qt1. 94percent.com